glp 1 and eye issues Blindness Risk GLP-1 medications and eye problem

For example, the lowest dose studied and approved for Zepbound (tirzepatide) is 2.5 mg

Cell Res 32 , 777780 (2022)

Our study now shows that if you are in a subgroup of long Covid patients who have autoantibodies circulating in your body, you may be a good candidate for these drugs." A commentary in Cell noted that the two studies provide compelling evidence that autoantibodies directly contribute to symptom generation in a subset of long Covid patients, while cautioning that neither provides definitive proof of a single central mechanism behind the condition

Avoided the nurse in question

Antioxidants (Basel) 11:1212